By Don Dion:
Inogen Inc. (INGN), a medical technology firm that markets portable oxygen concentrators for patients with chronic respiratory conditions, plans to raise $75 million in its upcoming IPO on Friday.
The Goleta, California-based firm will offer 4.4 million shares, including 20% insider shares, at an expected price range of $16-$18 per share. If the IPO can find the midpoint of that range at $17 per share, INGN will command a market value of $342 million.
INGN filed on November 27, 2013.
Lead Underwriters: J.P. Morgan Securities LLC
Underwriters: Leerink Partners LLC, Stifel Nicolaus & Company Inc, William Blair and Co. LLC
Summary of Inogen Inc. Business
INGN is a medical technology company, which develops, manufactures, and markets portable oxygen concentrators to be used in oxygen therapy for patients suffering from chronic respiratory conditions. The concentrators eliminate the need for these patients to rely on stationary oxygen concentrator systems. (These force patients
Complete Story »